Article

This article surveyed laws and regulations in all 50 states and the District of Columbia, as well as criminal and civil judicial decisions in which opioid treatment agreements were discussed as evidence, finding minimal evidence that they effectively reduce opioid misuse or improve patient outcomes.

Discusses how screening, brief intervention, and referral to treatment can be conducted by nurse practitioners in primary care; offers 1 CE credit

Reviews literature on payment options for screening, brief intervention, and referral to treatment and their barriers and facilitators in various settings

Provides overview of systematic reviews on substance use disorder treatment, finding that structural factors are the most common barriers and facilitators to treatment

Describes three steps to help family physicians seamlessly implement screening and brief intervention into their practice

Includes an infographic guide on the benefits of three medications for alcohol use disorder and provides a brief summary of treatment planning and medications approved by the Food and Drug Administration

Reviews the use of disulfiram, acamprosate, and naltrexone for alcohol use disorder (AUD) in primary care, and concludes that the knowledge and prescription of pharmacotherapy for AUD is insufficient

Review of findings on efficacy of using telehealth for treatment of substance use disorders (SUDs) including alcohol use disorder, suggesting limited evidence to date about telehealth compared to in-person care for SUDs

Review that provides guidance on how to integrate screening, brief intervention, and referral to treatment into clinical care through the use of technology, such as electronic health record systems or patient portals

Article with recommendations for implementation of screening for unhealthy alcohol use in primary care settings, including the use of patient screening tools and integration with electronic health record systems